Monoclonal antibodies in the clinic

Monoclonal antibodies in the clinic

Play all audios:

Loading...

Despite initial teething problems, the number of clinically effective monoclonal antibodies is growing. Access through your institution Buy or subscribe This is a preview of subscription


content, access via your institution RELEVANT ARTICLES Open Access articles citing this article. * SUPPRESSING IMMUNOTHERAPY BY ORGAN-SPECIFIC TUMOR MICROENVIRONMENTS: WHAT IS IN THE BRAIN?


* Chenyu Zhang *  & Dihua Yu _Cell & Bioscience_ Open Access 07 October 2019 * A RATIONAL APPROACH FOR CREATING PEPTIDES MIMICKING ANTIBODY BINDING * Sameer Sachdeva * , Hyun Joo *  


… Xiaoling Li _Scientific Reports_ Open Access 30 January 2019 ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per


year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated


during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Kohler, G. & Milstein, C. Continuous


cultures of fused cells secreting antibody of predefined specificity. _Nature_ 256, 495–497 (1975). Article  CAS  Google Scholar  * Carson, D.A. et al. Human lymphocyte hybridomas and


monoclonal antibodies. _Adv. Immunol._ 38, 275–311 (1986). Article  CAS  Google Scholar  * Morrison, S.L. et al. Chimeric human antibody molecules: mouse antigen-binding domains with human


constant region domains. _Proc. Natl. Acad. Sci. USA_ 81, 6851–6855 (1984). Article  CAS  Google Scholar  * Boulianne, G.L. et al. Production of functional chimaeric mouse/human antibody.


_Nature_ 312, 643–646 (1984). Article  CAS  Google Scholar  * Jones, P.T. et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse. _Nature_ 321,


522–525 (1986). Article  CAS  Google Scholar  * Reichert, J.M. New biopharmaceuticals in the USA: trends in development and marketing approvals 1995–1999. _Trends Biotechnol._ 18, 364–369


(2000). Article  CAS  Google Scholar  * DiMasi, J. Risks in new drug development: approval success rates for investigational drugs. _Clin. Pharmacol. Ther._ 69, 297–307 (2001). Article  CAS


  Google Scholar  * Fox, S. Biopharmaceutical contract manufacturing: meeting increased demand for capacity. (HighTech Business Decisions, Moraga, CA; 2001). Download references AUTHOR


INFORMATION AUTHORS AND AFFILIATIONS * senior research fellow at the Tufts Center for the Study of Drug Development, Tufts, Boston, MA Janice M. Reichert Authors * Janice M. Reichert View


author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reichert, J. Monoclonal


antibodies in the clinic. _Nat Biotechnol_ 19, 819–822 (2001). https://doi.org/10.1038/nbt0901-819 Download citation * Issue Date: September 2001 * DOI: https://doi.org/10.1038/nbt0901-819


SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to


clipboard Provided by the Springer Nature SharedIt content-sharing initiative